Search research articles
Contact Us
Filters
Showing results (81-90 of 109) with videos related to
Page
of 11
Sort By:
Clinical & Developmental Immunology
|
December 23, 2011
Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation
Sebastian Kobold, Sinje Tams, Tim Luetkens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 2013
Phase Ib study of panobinostat and bortezomib in relapsed or relapsed and refractory multiple myeloma
Jesús F San-Miguel, Paul G Richardson, Andreas Günther, et al.
Journal of the National Cancer Institute
|
June 30, 2012
Role of interleukin 16 in multiple myeloma
Djordje Atanackovic, York Hildebrandt, Julia Templin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 29, 2009
Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastases
Kristin Harris, Edward Chow, Liying Zhang, et al.
British Journal of Haematology
|
July 7, 2007
Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma
Martin Kropff, Guido Bisping, Elke Schuck, et al.
Annals of Hematology
|
September 19, 2003
Treatment of fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
Angelika Böhme, Markus Ruhnke, Dieter Buchheidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2009
Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study
Andreas Engert, Volker Diehl, Jeremy Franklin, et al.
Leukemia & Lymphoma
|
June 1, 2010
Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches
Monika Engelhardt, Martina Kleber, Josefina Udi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 23, 2008
The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22
Edward Chow, Amanda Hird, Galina Velikova, et al.
Haematologica
|
March 25, 2014
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network
Niels W C J van de Donk, Antonio Palumbo, Hans Erik Johnsen, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 109) with videos related to
Sort By:
Page
of 11
Clinical & Developmental Immunology
|
December 23, 2011
Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation
Sebastian Kobold, Sinje Tams, Tim Luetkens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 2013
Phase Ib study of panobinostat and bortezomib in relapsed or relapsed and refractory multiple myeloma
Jesús F San-Miguel, Paul G Richardson, Andreas Günther, et al.
Journal of the National Cancer Institute
|
June 30, 2012
Role of interleukin 16 in multiple myeloma
Djordje Atanackovic, York Hildebrandt, Julia Templin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 29, 2009
Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastases
Kristin Harris, Edward Chow, Liying Zhang, et al.
British Journal of Haematology
|
July 7, 2007
Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma
Martin Kropff, Guido Bisping, Elke Schuck, et al.
Annals of Hematology
|
September 19, 2003
Treatment of fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
Angelika Böhme, Markus Ruhnke, Dieter Buchheidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2009
Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study
Andreas Engert, Volker Diehl, Jeremy Franklin, et al.
Leukemia & Lymphoma
|
June 1, 2010
Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches
Monika Engelhardt, Martina Kleber, Josefina Udi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 23, 2008
The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22
Edward Chow, Amanda Hird, Galina Velikova, et al.
Haematologica
|
March 25, 2014
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network
Niels W C J van de Donk, Antonio Palumbo, Hans Erik Johnsen, et al.
Page
of 11